Synapse Open Synapse
Biology

Tanshinone IIA preconditioning enhances the therapeutic efficacy of mesenchymal stem cells in Alzheimer’s disease

Frontiers Cell & Developmental Biology · · 28 min read

BackgroundMesenchymal stem cells (MSCs) have the potential to treat Alzheimer’s disease (AD), but their therapeutic efficacy is limited by apoptosis and other complications during in vitro culture.

Latest from Frontiers Cell & Developmental Biology